Christopher R deFilippi
Overview
Explore the profile of Christopher R deFilippi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
2973
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goldberg J, deFilippi C, Lockhart C, McNair E, Sinha S, Kong H, et al.
Transplantation
. 2024 Dec;
PMID: 39630098
Background: Proteomic phenotyping can provide insights into rejection pathophysiology, novel biomarkers, and therapeutic targets. Methods: Within the prospective, multicenter Genomic Research Alliance for Transplantation study, 181 proteins were evaluated from...
2.
Daniels L, Ajongwen P, Christenson R, Clark C, Diercks D, Fermann G, et al.
J Appl Lab Med
. 2024 Nov;
10(2):325-338.
PMID: 39495056
Background: We evaluated the Vitros® Immunodiagnostic Products N-terminal pro B-type natriuretic peptide (NT-proBNP) II assay for aiding in diagnosis of heart failure (HF) in patients with acute dyspnea. Methods: Serum...
3.
Tan E, Choi H, deFilippi C, Oon Y, Chan S, Gong L, et al.
J Am Heart Assoc
. 2024 Sep;
13(19):e035486.
PMID: 39344657
Background: Echocardiographic indexes of aortic stenosis may not comprehensively reflect disease morbidity. Plasma proteomic profiling may add prognostic value in these patients. Methods And Results: Proximity extension assays (Olink) of...
4.
Cai X, White Q, Wang D, deFilippi C, Bertoni A, Wu C, et al.
J Am Heart Assoc
. 2024 Sep;
13(18):e037114.
PMID: 39235461
Background: Immigrants experience changes in cardiovascular risk factors and racial disparities in both cardiovascular health prevention and outcomes upon immigration. We aimed to examine cardiovascular risk factors and outcomes among...
5.
deFilippi C, Shah P, Shah S, Alemayehu W, Lam C, Butler J, et al.
Circ Heart Fail
. 2024 Aug;
17(9):e011792.
PMID: 39206547
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome that may emerge from overlapping systemic processes associated with comorbidities. We assessed whether unique clusters of circulating proteins...
6.
deFilippi C, Parashar Y, Awwad A
JACC Adv
. 2024 Jun;
3(2):100764.
PMID: 38939393
No abstract available.
7.
Neumann J, Twerenbold R, Weimann J, Ballantyne C, Benjamin E, Costanzo S, et al.
JAMA
. 2024 May;
331(22):1898-1909.
PMID: 38739396
Importance: Identification of individuals at high risk for atherosclerotic cardiovascular disease within the population is important to inform primary prevention strategies. Objective: To evaluate the prognostic value of routinely available...
8.
Greene S, Chambers R, Lerman J, Harrington J, deFilippi C, Wendell D, et al.
Eur J Heart Fail
. 2024 May;
26(6):1393-1398.
PMID: 38733160
Aims: The PARACOR-19 randomized controlled trial (RCT) was designed to examine the effects of sacubitril/valsartan on markers of cardiac injury, inflammation, structure, and function among patients who have recovered from...
9.
deFilippi C
Front Cardiovasc Med
. 2024 Apr;
11:1385509.
PMID: 38572305
The professional landscape for clinical cardiologists and most physicians has changed dramatically in the last decade in the United States. By the end of 2020, 87% of cardiologists were integrated...
10.
Leung J, Wu M, Kheradpour P, Chen C, Drake K, Tong G, et al.
Front Immunol
. 2024 Feb;
15:1348041.
PMID: 38318183
Background: Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to post-acute sequelae of SARS-CoV-2 (PASC) that can persist for weeks to years following initial viral infection. Clinical...